Ju Yang

This inventor holds 55 USPTO granted patents and 13 published patent applications and 19 EPO patents, primarily in PD-L1 Inhibitors (CPC class C07D). Top assignees: Chemocentryx, Inc., Amgen Inc., Other. Active years: 2013-2026.

USPTO Granted Patents = 55 (Patent Applications = 13)

% Patents Active = 100.0

EPO Patents = 19 (Patent Applications = 16)

Average Co-Inventor Count = 8.4

ph-index = 10

Forward Citations = 343(Granted Patents)

Forward Citations (Not Self Cited) = 170(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cupertino, CA (US) (2013 - 2015)
Palo Alto, PA (US) (2021)
Palo Alto, CA (US) (2014 - 2024)

Company Filing History:

1 out of 834,350

Other

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

PD-L1

CXCR7

CCR4

Immunomodulators

Chemokine Receptors

Azetidinyl

2-Oxindole

Triaryl Compounds

Heteroaryl-Biphenyl

Indane-Amine

Substituted Anilines

C5aR Antagonists

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12533354 - Triaryl compounds for treatment of PD-L1 diseases (2026-01-27),

2. 12497383 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases (2025-12-16),

3. 12448373 - Azetidinyl-acetamides as CXCR7 inhibitors (2025-10-21),

4. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases (2025-07-29),

5. 12139475 - 2-oxindole compounds (2024-11-12),

6. 12018016 - Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors (2024-06-25),

7. 12011439 - Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors (2024-06-18),

8. 11945805 - Inhibitors of CXCR2 (2024-04-02),

9. 11884654 - Substituted anilines as CCR(4) antagonists (2024-01-30),

10. 11872217 - Indanes as PD-L1 inhibitors (2024-01-16),

11. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases (2024-01-09),

12. 11820759 - Modulators of chemokine receptors (2023-11-21),

13. 11793771 - Immunomodulator compounds (2023-10-24),

14. 11759458 - Indane-amines as PD-L1 antagonists (2023-09-19),

15. 11713307 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases (2023-08-01),

Title: Inventor Ju Yang - Revolutionizing Technology in Palo Alto

Introduction: Ju Yang is a visionary inventor based in Palo Alto, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ju Yang holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a background in computer science and engineering, Ju Yang has worked with leading tech companies in Silicon Valley, where he has spearheaded projects that have pushed the boundaries of technological advancement.

Collaborations: Throughout his career, Ju Yang has collaborated with top researchers, engineers, and scientists to bring his innovative ideas to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge solutions in various industries.

Conclusion: Ju Yang's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in Palo Alto and beyond. His work continues to inspire the next generation of inventors and shape the future of technology.